All paxlovid articles
-
BusinessProtective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
Business
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
Opinion
The shadow of drug resistance
Why do some medicines stop working, and can we avoid it for Covid-19 antivirals?
